We are live on ! Find out more
BIM

Baldwin Investment Management Portfolio holdings

AUM $1.03B
1-Year Est. Return 22.29%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+22.29%
3 Year Est. Return
+74.82%
5 Year Est. Return
+112.14%
10 Year Est. Return
+391.06%
AUM
$374M
AUM Growth
+$30M
Cap. Flow
-$1.43M
Cap. Flow %
-0.38%
Top 10 Hldgs %
62.63%
Holding
175
New
9
Increased
27
Reduced
43
Closed
8

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.24M
2
STBA icon
S&T Bancorp
STBA
+$273K
3
XPO icon
XPO
XPO
+$271K
4
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$242K
5
LPT
Liberty Property Trust
LPT
+$215K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.96M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$651K
3
FDX icon
FedEx
FDX
+$322K
4
GLW icon
Corning
GLW
+$305K
5
DNBF
DNB Financial Corp
DNBF
+$263K

Sector Composition

Rank Sector Weight
1 Financials 61.12%
2 Technology 9.28%
3 Healthcare 6.81%
4 Consumer Discretionary 4.53%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSBC icon
151
HSBC
HSBC
$356B
$247K 0.07%
6,316
– –
XLP icon
152
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$246K 0.07%
3,900
– –
RDS.B
153
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$246K 0.07%
+4,104
New +$242K
PCAR icon
154
PACCAR
PCAR
$70.1B
$245K 0.07%
4,650
– –
CLX icon
155
Clorox
CLX
$12.7B
$242K 0.06%
1,575
– –
IYY icon
156
iShares Dow Jones US ETF
IYY
$3.06B
$241K 0.06%
3,020
– –
GLD icon
157
SPDR Gold Trust
GLD
$141B
$229K 0.06%
1,600
– –
MET icon
158
MetLife
MET
$62.1B
$225K 0.06%
4,407
– –
LPT
159
DELISTED
Liberty Property Trust
LPT
$225K 0.06%
+3,750
New +$215K
AXP icon
160
American Express
AXP
$230B
$219K 0.06%
1,760
– –
TCOM icon
161
Trip.com Group
TCOM
$29.1B
$217K 0.06%
+6,466
New +$208K
PM icon
162
Philip Morris
PM
$295B
$211K 0.06%
+2,475
New +$204K
VB icon
163
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$209K 0.06%
+1,262
New +$201K
LMT icon
164
Lockheed Martin
LMT
$136B
$208K 0.06%
535
– –
NVS icon
165
Novartis
NVS
$297B
$203K 0.05%
+2,142
New +$192K
GSK icon
166
GSK
GSK
$106B
$202K 0.05%
+3,440
New +$191K
CHRW icon
167
C.H. Robinson
CHRW
$17.5B
– –
-2,550
Closed -$216K
CSCO icon
168
Cisco
CSCO
$479B
– –
-4,109
Closed -$203K
GLW icon
169
Corning
GLW
$143B
– –
-10,700
Closed -$305K
IBM icon
170
IBM
IBM
$224B
– –
-1,641
Closed -$228K
WFC icon
171
Wells Fargo
WFC
$264B
– –
-3,985
Closed -$201K
CBM
172
DELISTED
Cambrex Corporation
CBM
– –
-3,900
Closed -$232K
DNBF
173
DELISTED
DNB Financial Corp
DNBF
– –
-5,918
Closed -$263K
CELG
174
DELISTED
Celgene Corp
CELG
– –
-19,695
Closed -$1.96M
3 4 5 6
7

Similar funds

CM
Condire Management Dallas, Texas $1.03B AUM 162.78% 1-Year Est. Return
CFFNO
Common Fund For Nonprofit Organizations Wilton, Connecticut $1.03B AUM 22.44% 1-Year Est. Return
TBA
Tower Bridge Advisors Conshohocken, Pennsylvania $1.04B AUM 23.66% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return
OPFM
Optimus Prime Fund Management Grand Cayman, Cayman Islands $1.04B AUM 9.64% 1-Year Est. Return
RC
RDST Capital Seattle, Washington $1.04B AUM 0.4% 1-Year Est. Return

Baldwin Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Baldwin Investment Management held 175 positions worth $374M, up 8.7% from $344M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Baldwin Investment Management's Q4 2019 filing shows 9 new, 27 increased, 43 reduced and 8 closed positions. Its largest new stake was S&T Bancorp: 7,218 shares worth $291K. The largest sale was Celgene Corp, an estimated $1.96M.

By sector, the portfolio is most concentrated in Financials at 61% of assets, up from 61% a quarter earlier, followed by Technology and Healthcare.

  • Baldwin Investment Management's largest Q4 2019 buy was S&T Bancorp: 7,218 shares worth $291K.
  • Baldwin Investment Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.24M increase.
  • Baldwin Investment Management's biggest Q4 2019 reduction was Berkshire Hathaway Class A, cutting an estimated $651K.
  • Baldwin Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.96M.
  • Baldwin Investment Management's ten largest holdings make up 63% of its $374M portfolio in Q4 2019.
  • Baldwin Investment Management opened 9 new positions and closed 8 in Q4 2019.
  • Baldwin Investment Management's portfolio value rose 8.7% quarter-over-quarter to $374M.

Based on Baldwin Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.